Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CAR-T THERAPY

The New England Journal of Medicine

Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy

Hematology/Oncology February 5th 2024

Dana-Farber Cancer Institute

Exploring How CAR T-Cell Therapy May Help More Patients

Hematology/Oncology January 22nd 2024

OBR Oncology

FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates

Hematology/Oncology January 16th 2024

Hematology Advisor

New CAR-T Therapy May Pave Way for Universal Targeting of Blood Cancers

Hematology October 9th 2023

The New England Journal of Medicine

Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia

Hematology/Oncology September 11th 2023


Study Finds Hallmarks of T Cell Exhaustion Within Hours of Tumor Exposure

Oncology, Medical August 14th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form